For the Inventor, By the Inventor

Enter assignee name

Mutabilis

USPTO Granted Patents = 10

% Expired Patents = 10.0

EPO Patents = 10

Forward Citations = 0

Loading Chart...

Loading Chart...

26 inventors (with patents filed for the assignee):

Francis Chevreuil (9 out of 14 patents)

Sophie Chasset (8 out of 17 patents)

Christophe Simon (8 out of 9 patents)

4. Julie Brias (7 out of 8 patents)

5. Nicolas Lecointe (7 out of 7 patents)

6. Frédéric Le Strat (7 out of 13 patents)

7. Julien Barbion (7 out of 9 patents)

8. Audrey Caravano (7 out of 8 patents)

9. Fabien Faivre (6 out of 8 patents)

10. Sébastien Richard (5 out of 8 patents)

11. Benoît Ledoussal (5 out of 5 patents)

12. Sophie Vomscheid (5 out of 6 patents)

13. Chrystelle Oliveira (4 out of 4 patents)

14. Géraldine Le Fralliec (3 out of 3 patents)

15. Rémi Lebel (2 out of 2 patents)

10 patents: Sort by Forward Citations

1. 11865118 - Heterocyclic compounds and their use in preventing or treating bacterial infections (2024-01-09),

2. 11530227 - Heterocyclic compounds and their use in preventing or treating bacterial infections (2022-12-20),

3. 10842779 - Heterocyclic compounds and their use in preventing or treating bacterial infections (2020-11-24),

4. 10722520 - Heterocyclic compounds and their use in preventing or treating bacterial infections (2020-07-28),

5. 10570131 - Heterocyclic compounds and their use in preventing or treating bacterial infections (2020-02-25),

6. 10501481 - Heterocyclic compounds and their use in preventing or treating bacterial infections (2019-12-10),

7. 10301305 - Heteroaromatic derivatives and their use as pharmaceuticals (2019-05-28),

8. 10183943 - Heterocyclic compounds and their use in preventing or treating bacterial infections (2019-01-22),

9. 10072006 - Heterocyclic compounds and their use in preventing or treating bacterial infections (2018-09-11),

10. 9975911 - Antibacterial compounds and biological applications thereof (2018-05-22),

Mutabilis is a biotechnology company specializing in the development of novel antibiotics to combat antibiotic-resistant bacteria. With a focus on utilizing cutting-edge technology and innovative research approaches, Mutabilis is dedicated to addressing the growing global health threat of antibiotic resistance. The company's mission is to discover and develop new antibiotics to save lives and improve public health.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

10 Patents

#360 in Paris

#1,705 in France

#55,954 in the World

Mutabilis

Forward Citations = 0

26 inventors:

Francis Chevreuil (9 out of 14 patents)

Sophie Chasset (8 out of 17 patents)

Christophe Simon (8 out of 9 patents)

4. Julie Brias (7 out of 8 patents)

5. Nicolas Lecointe (7 out of 7 patents)

Please report any incorrect information to [email protected]

Loading…